Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 11/20 | 0.58 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | AKR1B1 | P15121 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.32 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23908751 | 0.93 | S1PR2 (0.67) | S1PR2EGLN1LMNAAKR1B1MAPT | |
| SCHEMBL23914843 | 0.90 | S1PR2 (0.54) | S1PR2EGLN1LMNAMAPTTP53 | |
| SCHEMBL23915331 | 0.89 | S1PR2 (0.55) | S1PR2EGLN1AKR1B1MAPTTP53 | |
| SCHEMBL23908773 | 0.87 | S1PR2 (0.58) | S1PR2EGLN1LMNATP53 | |
| SCHEMBL23908777 | 0.84 | S1PR2 (0.51) | S1PR2EGLN1MAPTTP53 | |
| SCHEMBL23908798 | 0.83 | S1PR2 (0.66) | S1PR2EGLN1AKR1B1TP53 | |
| SCHEMBL23908754 | 0.81 | S1PR2 (0.67) | S1PR2AKR1B1 | |
| SCHEMBL23908873 | 0.81 | S1PR2 (0.68) | S1PR2AKR1B1MAPT | |
| SCHEMBL23915327 | 0.80 | S1PR2 (0.54) | S1PR2EGLN1LMNAMAPTTP53 | |
| SCHEMBL23908727 | 0.79 | S1PR2 (0.69) | S1PR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3649119-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS | GALAPAGOS NV (BE) | 2021-11-03 | — | — | EP | disclosed |